Video

ACC 2018: SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs

Published: 17 Apr 2018

  • Views:

    Views Icon 65
  • Likes:

    Heart Icon 0

 

Mikhail Kosiborod discusses the CVD-REAL 2 study - Lower Risk of Cardiovascular Events and Death Associated With Initiation of SGLT-2 Inhibitors Versus Other Glucose Lowering Drugs.

Filmed on-site at the American College of Cardiology congress 2018 in Orlando, USA.